(702) 683-8946

Monday - Friday 9am to 5pm



Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more




Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com




CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business




Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.


5 Result: NYSE:MDT

New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker

August 28th, 2016

Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS DUBLIN and ROME / CRWE PRESS RELEASE / AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients. Read more

Medtronic Completes $20 Million Second Tranche Investment In Mazor Robotics

August 15th, 2016

CAESAREA, Israel / CRWE PRESS RELEASE / August 15, 2016 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical guidance systems, today announced the completion of the second tranche of the equity inv. Read more

Medtronic to Expand Heart Failure Portfolio with Acquisition of HeartWare International

June 27th, 2016

Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector DUBLIN and FRAMINGHAM, Mass. / CRWE PRESS RELEASE / June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare Internati. Read more

Medtronic Reports Second Quarter Financial Results

December 03rd, 2015

Revenue of $7.1 Billion Grew 6% on a Comparable, Constant Currency Basis; 62% as Reported Non-GAAP Diluted EPS of $1.03; GAAP Diluted EPS of $0.36 Free Cash Flow of $1.1 Billion; GAAP Cash Flow from Operations of $1.3 Billion Company Updates Rev. Read more

World' Smallest Pacemaker, Medtronic Micra(R) TPS, Meets Global Clinical Trial's Safety and Effectiveness Endpoints

November 09th, 2015

Data Presented at AHA and Simultaneously Published in the New England Journal of Medicine Demonstrate High Implant Success and Reduced Healthcare Utilization DUBLIN and ORLANDO / CRWEPRESSRELEASE / Nov. 9, 2015 - In the largest clinical dat. Read more

Load More Content